Guolian Securities
VC Fund
Wuxi, China
Guolian Securities is a VC fund in Wuxi focused on Manufacturing and Electronics. Guolian Securities has formed a brokerage business, investment banking, asset management and investment, securities investment and credit transactions, such as a more complete business system. In Jiangsu, Shanghai, Beijing, Zhejiang, Guangdong, Guangxi, Chongqing, Shandong, Jiangxi and Hunan provinces and cities in important areas set up a branch.In the industry earlier launched the national call center 95570, net capital yield and cost management capabilities and other indicators ranked outstanding performance.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Guolian Securities invests in
Stages Guolian Securities invests in
Countries Guolian Securities invests in
Investment Focus
Industry
- Manufacturing 4 (36%)
- Electronics 3 (27%)
- Pharmaceutical 3 (27%)
- Health Care 2 (18%)
- Biotechnology 2 (18%)
Stage
- Series B 5 (45%)
- Post-IPO Equity 2 (18%)
- Series A 1 (9%)
- Series C 1 (9%)
- Series D 1 (9%)
Country
- China 9 (82%)
- Germany 1 (9%)
- Hong Kong 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tongchao Precision Machinery
|
Tongchao Precision Machinery develops high-precision electrodes for chemical vapor deposition and DRY (dry etching) equipment. The company's products are used in key core equipment for the production of liquid crystal panels and semiconductor chips. | $14.2M / Venture - Series Unknown / Dec 23, 2025 | |
BEM Power
|
BEM Power is an electrical manufacturing company that specializes in the manufacturing of alternators, generators, ship control systems and motor products. | $13.8M / Series B / Jun 13, 2024 | |
Hong Jing Drive
|
Hong Jing Drive is a full-stack autonomous driving solution provider. Automatic driving computing platform, selection and layout of sensors, full-stack software system integration, and calibration for automatic driving. Hong Jing Drive was established on May 2, 2018 by Feilong Liu in Hangzhou, Zhejiang. | $13.7M / Series B / Sep 14, 2023 | |
Riyu Photovoltaic
|
Riyu Photovoltaic specializes in the development of solar cell front silver paste materials. | $14.2M / Series A / Aug 27, 2023 | |
China Resources Pharmaceutical Group
|
China Resources Pharmaceutical Group operates as a pharmaceutical company. The Company researches, develops, manufactures, and distributes Chinese, western, and other medicines and health foods. China Resources Pharmaceutical serves customers throughout China. | $88.5M / Series B / Jan 10, 2023 | |
Indiemicro
|
Indie microelectronics combines R&D, testing, platform development, application development, technical support, and sales centers. Sales and technical support centers have been established in Shanghai, Shenzhen, and Taipei with a focus on supporting semiconductor products for Great China customers. | $43M / Series B / Dec 12, 2022 | |
Cygnus Biosciences
|
Cygnus Biosciences (Beijing) Co., Ltd. is a high-tech company specializing in R & D and industrialization of gene sequencing platform and committed to clinical medicine screening and diagnosis. | $29.6M / Series C / Aug 05, 2022 | |
xuelangyun
|
Xuelangyun is a general platform for industrial Internet. It is developed and operated by Wuxi Xuelang Digital Technology Co., Ltd. The company is committed to building a national-level industrial Internet platform and creating an independent and controllable industrial data operating system. The core team is from Alibaba Cloud, and the founder isthe head of the former Alibaba Cloud ET Industrial Brain. | $44.2M / Series B / May 15, 2022 | |
Adlai Nortye
|
Adlai Nortye is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs, with its R&D and global clinical operation centers in both China and the United States. With a strategic emphasis on oncology, it has built a global pipeline through collaborations and internal discoveries with more than 10 drug candidates indevelopment. | $100M / Series D / Jul 13, 2021 | |
YUNCHANGGAME.COM
|
YUNCHANGGAME.COM is a mobile phone game development company. | $14.2M / Post-IPO Equity / Apr 18, 2016 | |
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Guolian Securities invest in?
Guolian Securities invests primarily in Manufacturing, Electronics and Pharmaceutical startups, most often at Series B and Post-IPO Equity stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Guolian Securities last invest?
The most recent investment recorded for Guolian Securities closed in Dec 2025. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
